Compare Nuwellis Inc (NUWE) vs ProShares UltraPro QQQ ETF (TQQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs ProShares UltraPro QQQ ETF — how do they compare? Nuwellis Inc trades at $1.42 (market cap $542.80K), while ProShares UltraPro QQQ ETF trades at $74.53. The key difference: ProShares UltraPro QQQ ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | TQQQ | |
|---|---|---|
Market Cap | $542.80K | — |
Sector | Technology | Leveraged / Inverse |
52-Week High | $220.50 | $87.22 |
52-Week Low | $1.42 | $37.89 |
Enterprise Value | -$1.27M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $1.41, down 0.7% on the day, with a bearish technical signal driven by moving averages. The company shows strong revenue growth, with preliminary Q2 2026 revenue up 14% year-over-year, but remains unprofitable with a net income margin of -217.22%. Recent developments include a reverse stock split, new CEO appointment, and expansion of its Aquadex platform into new pediatric markets. Cash flow from operations is negative, though recent financing activities have provided capital.
The outlook is mixed: growth initiatives and analyst support offer potential, but persistent losses and high cash burn pose significant risks. Investors should weigh the company's expansion against its financial sustainability.
TQQQ trades at $75.13, up 1.82% with a bullish technical signal supported by moving averages. The ETF leverages Nasdaq-100 exposure, amplified by 3x daily returns. Recent institutional buying includes Bay Colony Advisory's 7,786 share acquisition. Technical indicators show RSI at 74.38 suggesting overbought conditions, while ADX indicates strong trend momentum. Support levels begin at $72 with resistance at $74-$76.
Outlook remains positive given AI-driven tech momentum, but leverage amplifies volatility risks. The ETF's structural costs compound daily, potentially eroding long-term returns despite short-term gains. Investors face significant downside risk during market corrections, as evidenced by recent 14% single-day declines. Current levels warrant caution despite bullish technicals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About ProShares UltraPro QQQ ETF
TQQQ is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the Nasdaq-100 Index. It is one of the most liquid and actively traded instruments in the market, designed for sophisticated traders to amplify short-term bullish exposure to large-cap non-financial growth stocks, predominantly in the technology and communication sectors.
Read more on TQQQ →
